Results 221 to 230 of about 31,156,887 (403)

Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor.

Journal of Clinical Oncology, 2015
J. Kochenderfer, M. Dudley, Sadik H. Kassim, R. Somerville, R. O. Carpenter, M. Stetler-Stevenson, J. Yang, G. Phan, M. Hughes, R. Sherry, M. Raffeld, Steven R. Feldman, Lily Lu, Yong F Li, L. Ngo, A. Goy, T. Feldman, D. Spaner, Michael L. Wang, Clara C. Chen, S. Kranick, A. Nath, Debbie-Ann N. Nathan, K. Morton, M. A. Toomey, S. Rosenberg   +25 more
semanticscholar   +1 more source

Comprehensive omics‐based classification system in adult patients with B‐cell acute lymphoblastic leukemia

Molecular Oncology, EarlyView.
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song, Ting Liu, Qishan Hao, Qiuyun Fang, Xiaoyuan Gong, Yan Li, Zheng Tian, Hui Wei, Min Wang, Jianxiang Wang, Tao Cheng, Yingchang Mi   +11 more
wiley   +1 more source

B-cell subsets in leprosy lesions: unraveling the complex interplay. [PDF]

An Bras Dermatol
Fróes LAR, Pagliari C, Trindade MAB, Sotto MN.   +3 more
europepmc   +1 more source

Specific Suppression of Delayed Hypersensitivity: The Possible Presence of a Suppressor B Cell in the Regulation of Delayed Hypersensitivity [PDF]

, 1974
Ruth Neta, S. B. Salvin
openalex   +1 more source

Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma

Cell, 2017
Anupama Reddy, Jenny Zhang, Nicholas S. Davis, Andrea B. Moffitt, C. Love, A. Waldrop, S. Leppa, A. Pasanen, L. Meriranta, M. Karjalainen-Lindsberg, P. Nørgaard, M. Pedersen, A. Gang, E. Høgdall, Tayla B. Heavican, Waseem G Lone, J. Iqbal, Qiu Qin, Guojie Li, S. Kim, J. Healy, K. Richards, Y. Fedoriw, L. Bernal-Mizrachi, J. Koff, A. Staton, C. Flowers, O. Paltiel, N. Goldschmidt, M. Calaminici, A. Clear, J. Gribben, Evelyn T. Nguyen, M. Czader, S. Ondrejka, A. Collie, E. Hsi, E. Tse, R. Au-Yeung, Y. Kwong, G. Srivastava, W. Choi, A. Evens, M. Pilichowska, M. Sengar, N. Reddy, Shaoying Li, A. Chadburn, L. Gordon, E. Jaffe, S. Levy, R. Rempel, Tiffany J Tzeng, Lanie E. Happ, Tushar Dave, D. Rajagopalan, J. Datta, D. Dunson, S. Dave   +58 more
semanticscholar   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source

Computational modelling of aggressive B-cell lymphoma. [PDF]

Biochem Soc Trans
Jayawant ES, Vareli A, Pepper A, Pepper C, Simoes F, Mitchell S.   +5 more
europepmc   +1 more source

T and B lymphocyte antigen-positive null cell leukemias [PDF]

, 1977
Joseph Kaplan, Y Ravindranath, WD Jr Peterson   +2 more
openalex   +1 more source

Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment

Molecular Oncology, EarlyView.
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop, Edgar Cardenas De La Hoz, Hanne Verswyvel, Joey De Backer, Ho Wa Lau, Angela Privat‐Maldonado, Wim Vanden Berghe, Steve Vanlanduit, Evelien Smits, Annemie Bogaerts, Abraham Lin   +10 more
wiley   +1 more source

Author Correction: Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model

npj Vaccines, 2023
Julia Ludwig, Stephen W. Scally, Giulia Costa, Sandro Hoffmann, Rajagopal Murugan, Jana Lossin, Katherine Prieto, Anna Obraztsova, Nina Lobeto, Blandine Franke-Fayard, Chris J. Janse, Celia Lebas, Nicolas Collin, Spela Binter, Paul Kellam, Elena A. Levashina, Hedda Wardemann, Jean-Philippe Julien   +17 more
doaj   +1 more source